CRINETICS PHARMACEUTICALS IN

Ticker: CRNX CUSIP: 22663K107 Class: EQTY

Brevan Howard Capital Management LP's Holding History (CIK: 0001512857)

Note: Option positions (PUT/CALL) are excluded.

Q3 2025
Shares 11,969 Value ($000) $499 Avg Close $31.97 Range $25.83 - $47.41
Q4 2024
Shares 9,777 Value ($000) $500 Avg Close $55.95 Range $49.48 - $62.53